4,5-diphenyl-2-oxazole-propionic acid monoethanolamine salt

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 4,5-diphenyl-2-oxazole-propionic acid monoethanolamine salt
• 英文别名: 4,5-diphenyl-2-oxazolepropionic acid monoethanolamine salt；4,5-diphenyl-2-oxazole-propionic acid monoethanolamine；2-Aminoethanol;3-(4,5-diphenyl-1,3-oxazol-2-yl)propanoic acid
• 化学式: C₂H₇NO*C₁₈H₁₅NO₃
• 分子量: 354.406
• InChiKey: PIMCXYPXOPOJBO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.96
• 重原子数：
  26
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  110
• 氢给体数：
  3
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  奥沙普秦 、 C.I.酸性橙108 以 乙酸乙酯 为溶剂， 生成 4,5-diphenyl-2-oxazole-propionic acid monoethanolamine salt
  参考文献：
  名称：

  Oxaprozin or closely related compound for the treatment and prevention of pruritus

  摘要：

  本发明提供了治疗瘙痒症的方法和药物，包括治疗与皮肤病相关的瘙痒症，通过局部给药或全身给药氧氯氮或其密切相关化合物或其盐来治疗基础疾病。

  公开号：

  EP1707199A1

文献信息

• Dermatological compositions comprising oxaprozin or a closely related compound for the treatment of dermatological diseases
  申请人：Astion Development A/S

  公开号：EP1707200A1

  公开（公告）日：2006-10-04

  The invention relates to dermatological compositions of Oxaprozin or a closely related compound suitable adapted for the treatment of a dermatological disease, where at least two of the enzymes selected from protein tyrosine kinase Syk, protein tyrosine kinase ZAP-70 and phosphodiesterase IV play a role in mediating the dermatological disease. The invention also encompasses dermatological compositions for the treatment of pruritus.

  本发明涉及奥沙普秦或密切相关化合物的皮肤病组合物，适用于治疗皮肤病，其中至少两种酶选自蛋白酪氨酸激酶Syk、蛋白酪氨酸激酶ZAP-70和磷酸二酯酶IV，它们在介导皮肤病中发挥作用。本发明还包括用于治疗瘙痒症的皮肤病组合物。
• Oxaprozin or a closely related compound for the treatment of eczema
  申请人：Astion Development A/S

  公开号：EP1707201A1

  公开（公告）日：2006-10-04

  The present invention relates to a novel principle of treating dermatological diseases comprising inhibiting several crucial steps in the inflammatory cascade including at least the inhibition of one or more of the enzymes Protein tyrosine kinase Syk, Protein tyrosine kinase ZAP-70 and phosphodiesterase IV (PDE-IV). The invention provides medicaments and methods for the treatment of inflammatory dermatological diseases, particularly eczemas, comprising Oxaprozin or a closely related compound or a salt thereof.

  本发明涉及一种治疗皮肤病的新原理，包括抑制炎症级联反应中的几个关键步骤，至少包括抑制一种或多种酶蛋白酪氨酸激酶Syk、蛋白酪氨酸激酶ZAP-70和磷酸二酯酶IV（PDE-IV）。本发明提供了治疗炎症性皮肤病，特别是湿疹的药物和方法，其中包含 Oxaprozin 或一种密切相关的化合物或其盐。
• Dermatological compositions and salts for the treatment of dermatological diseases
  申请人：Weidner Sloth Morten

  公开号：US20060222671A1

  公开（公告）日：2006-10-05

  The invention relates to dermatological compositions of Oxaprozin or a closely related compound suitable adapted for the treatment of a dermatological disease, where at least two of the enzymes selected from protein tyrosine kinase Syk, protein tyrosine kinase ZAP-70 and phosphodiesterase IV play a role in mediating the dermatological disease. The invention also encompasses dermatological compositions for the treatment of pruritus.

  本发明涉及奥沙普秦或密切相关化合物的皮肤病组合物，适用于治疗皮肤病，其中至少两种酶选自蛋白酪氨酸激酶Syk、蛋白酪氨酸激酶ZAP-70和磷酸二酯酶IV，它们在介导皮肤病中发挥作用。本发明还包括用于治疗瘙痒症的皮肤病组合物。
• Treatment of eczemas
  申请人：Weidner Sloth Morten

  公开号：US20060229347A1

  公开（公告）日：2006-10-12

  The present invention relates to a novel principle of treating dermatological diseases comprising inhibiting several crucial steps in the inflammatory cascade including at least the inhibition of one or more of the enzymes Protein tyrosine kinase Syk, Protein tyrosine kinase ZAP-70 and phosphodiesterase IV (PDE-IV). The invention provides medicaments and methods for the treatment of inflammatory dermatological diseases, particularly eczemas, comprising Oxaprozin or a closely related compound or a salt thereof.

  本发明涉及一种治疗皮肤病的新原理，包括抑制炎症级联反应中的几个关键步骤，至少包括抑制一种或多种酶蛋白酪氨酸激酶Syk、蛋白酪氨酸激酶ZAP-70和磷酸二酯酶IV（PDE-IV）。本发明提供了治疗炎症性皮肤病，特别是湿疹的药物和方法，其中包含 Oxaprozin 或一种密切相关的化合物或其盐。
• Treatment or prevention of pruritus
  申请人：Weidner Sloth Morten

  公开号：US20060251689A1

  公开（公告）日：2006-11-09

  The invention provides methods and medicaments for the treatment of pruritus in general or pruritus caused by or associated with dermatological diseases including the treatment of the underlying disease by topically administering to skin or by systemically administering to a subject Oxaprozin or a closely related compound or a salt thereof.